Mr Simon Marks > Epstein Rosenblum Maoz (ERM) > Tel Aviv, Israel > Lawyer Profile

Epstein Rosenblum Maoz (ERM) ‘excels in handling complex, high-stakes cross-border M&A deals, with unmatched regulatory expertise’. Its work encompasses advice on clinical trials, IP, venture capital funding, and much more. The practice is led by corporate and VC specialist Ron Abelski, who is ‘a trusted advisor and an excellent negotiator’, and cross-border financing expert Simon Marks, who ‘solves complicated issues’. Abelski recently acted for a leading global provider of products and services for patients with chronic kidney failure in the negotiation of commercial contracts, and the import and distribution of pharmaceuticals, medical devices, and disposables in Israel.

Offering ‘practical advice that aligns with business goals’, Epstein Rosenblum Maoz (ERM) is noted for its cross-border experience, with the team acting for a raft of international tech companies and investors — it also represents Israeli start-ups and investors. Department head Simon Marks provides ‘clear guidance on complicated issues’. Also recommended are: corporate and M&A head Nimrod Rosenblum; Ron Abelski, who fronts the German desk; and corporate and finance partner Jeremy Seeff.

Epstein Rosenblum Maoz (ERM) boasts a robust corporate, M&A, and private equity practice that advises a diverse range of buyers, sellers, investors, and financial institutions on various M&A transactions. The team also has extensive experience managing cross-border corporate transactions across the financial services, energy, technology, and communications sectors. Practice head Nimrod Rosenblum serves as a key contact for private equity transactions, Simon Marks handles financing transactions, and Rotem Perelman Farhi is an expert in complex technology and commercial transactions. With expertise in venture capital investments, Jeremy Seeff and Errel Peli are also recommended.